Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
NICE Systems Ltd (NICE) PT Lowered to $133 at Cantor Fitzgerald on Limited Visibility
-
Cantor Fitzgerald Starts FormFactor (FORM) at Overweight
-
Invivyd prices $125 million public offering at $2.50 per share
-
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
-
UBS O'Connor's capital solutions strategy co-heads did not accept jobs at Cantor, source says
-
Figure files registration for blockchain-native equity securities offering
-
Figure Announces Public Filing of Registration Statement for Proposed Offering of Tradeable, Blockchain-Native Equity Securities
-
Nuvalent announces $500 million public stock offering
-
Invivyd announces public offering of common stock
-
Invivyd Announces Proposed Public Offering of Common Stock
-
Nuvalent Announces Public Offering of Common Stock
-
Avrio Announces the Appointment of James O'Neill as Chief Investment Officer to Lead Global Investment and Capital Markets Strategy
-
Merlin Labs increases PIPE funding to over $200 million for SPAC deal
-
Merlin Labs, Inc. and Inflection Point Acquisition Corp. IV Announce Upsizing of PIPE Investment to More Than $200 Million
-
Serve Robotics's (SERV) Implied FY26 Outlook Encouraging - Cantor Fitzgerald
-
EVgo (EVGO) is 'Best-Positioned in the EV Charging Industry' - Cantor Fitzgerald
-
Kodiak AI (KDK) Benefits from Faster Autonomous Vehicle Deployment - Cantor Fitzgerald
-
Rocket Lab USA (RKLB) PT Raised to $72 at Cantor Fitzgerald
-
CrowdStrike Holdings (CRWD) PT Raised to $590 at Cantor Fitzgerald on Positive Checks
-
Zscaler (ZS) PT Raised to $365 at Cantor Fitzgerald on upbeat checks, SASE Opportunity
-
Fermi (FRMI) Will 'March Out of Pre-Revenue Status Next Year' - Cantor Fitzgerald
-
NVIDIA (NVDA) 'Remains Our Hands-Down TOP PICK' - Citizens
-
Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy
-
Form 13F-NT CANTOR FITZGERALD & CO. For: Sep 30
-
Form 13F-NT Cantor Fitzgerald Europe For: Sep 30
-
Form 13F-HR CANTOR FITZGERALD, L. For: Sep 30
-
Euro Sun Welcomes Romania’s Steps to Adopt the European Union’s Critical Raw Materials Act and Reports Stronger Project Economics With NPV Rising to US$1.78 Billion at Rovina Valley
-
Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth
-
Cantor Fitzgerald Reiterates Overweight Rating on Taysha Gene Therapies (TSHA)
-
Applied Materials (AMAT) Shares At an Important Inflection - Cantor Fitzgerald
-
Stratasys (SSYS) PT Raised to $13.50 at Cantor Fitzgerald Amid Challenging Macro
-
Upexi (UPXI) PT Lowered to $6 at Cantor Fitzgerald Ex-Treasury Operations Value
-
Trevi (TRVI) First to Show Positive IPF Chronic Cough, RCC Data - Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Aardvark Therapeutics Inc (AARD)
-
Intuitive Machines (LUNR) Has Several Key Material Catalysts - Cantor Fitzgerald
-
Eupraxia's (EPRX) Blockbuster Opportunity Not Fully Priced In - Cantor Fitzgerald
-
Cantor Fitzgerald Starts DiaMedica Therapeutics Inc. (DMAC) at Overweight
-
Form 10-Q Cantor Fitzgerald Income For: Sep 30
-
Verastem Oncology prices $90 million stock offering at $7.25 per share
-
Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants
-
Verastem Oncology announces public offering of common stock
-
Verastem Oncology Announces Proposed Public Offering of Common Stock
-
Biohaven closes $200M public offering at $7.50 per share
-
Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M
-
Terawulf Inc. (WULF) PT Lowered to $18 at Cantor Fitzgerald
-
Grayscale Investments® Announces Public Filing of Registration Statement for Proposed Initial Public Offering
-
Securitize submits draft Form S-4 for CEPT merger to SEC
-
Securitize and Cantor Equity Partners II Announce Confidential Submission of Draft Registration Statement on Form S-4 with the U.S. Securities and Exchange Commission
-
Serve Robotics' (SERV) 2000 Robots by Dec Plan Encouraging - Cantor Fitzgerald
-
Gossamer Bio's (GOSS) Seralitinib Data Likely Comes Out by Feb - Cantor Fitzgerald

